Nevro stock: buy or sell?

NVRO stock price: $105.19 0.20% At close on November 15th, 2019

Updated on:
November 15th, 2019

0

Nevro stayed steady 0.20% yesterday to $105.19 after marking all time highs on Nov/7. On Nov/7 NVRO climbed an exceptional 17.54%.

Nevro Corp., a medical device company, provides products for the patients suffering from chronic pain in the United States and internationally.

Should I buy Nevro stock?

Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. That's why is so important to define your own trading strategy that fits your character as inversor. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

Currently, Nevro stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is Nevro stock a buy?

Financial institutions and banks publish stock ratings everyday. At Stocks2.com, we collected 11 ratings published for NVRO stock in the last 30 days.

The general sentiment of these ratings is bullish for NVRO stock, with 9 positive ratings.
Is NVRO a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-8-9Canaccord Genuityn/aHold
2019-8-9Bank of American/aBuy
2019-8-9Bank of American/aBuy
2019-8-12JMP Securitiesn/aMarket Outperform
2019-5-13Wells Fargo & Con/aOutperform
2019-5-10Morgan Stanleyn/aOverweight
2019-3-20Wells Fargo & CoMarket PerformOutperform
2019-3-20Morgan Stanleyn/aOverweight
2019-3-20Canaccord Genuityn/aBuy
2019-3-20Bank of AmericaNeutralBuy
2019-2-22BMO Capital MarketsOutperformMarket Perform

Nevro stock analysis

Daily outlook

After reaching all time highs on Nov 7th, Nevro stayed constant 0.20% yesterday to $105.19.

On Nov/7, NVRO hit new all time highs, pushing higher previous ATH of $106.93 recorded . New ATHs are usual entry points for many trading setups as there aren't higher resistences. Nevro stayed constant 0.20% to $105.19 after topping to all time highs on Nov 7th. On August NVRO price bounced up over the SMA of 100 days demonstrating to be a significant support for this stock.

NVRO stock chart (daily)

Weekly outlook

After boosting an outstanding 17.96% in a week last week, Nevro closed this week at $105.19 and stayed stable a lame -0.38%. Late September NVRO plunged a chilling -6.52% in just one week. This week broke a streak of 4 green weeks.

Not so far away is the last all-time high Nevro marked last week. Nevro stock is trading in the range of its last top and last bottom. Loosing would mean breaking the current uptrend. Breakdowns under last bottom are selling point signals for some trading strategies. Since mid May when SMA20w and SMA40w crossed up, NVRO price gained $44.99 per share (74.73%). Since mid March when NVRO stock price broke up the SMA40w line, it gained $61.50 (140.76%).

NVRO stock chart (weekly)

Nevro stock price history

Nevro IPO was on November 6th, 2014 at $23.40 per share1. Since then, NVRO stock surged a 349.50%, with a yearly average of 69.90%. If you had invested $1,000 in Nevro stock in 2014, it would worth $3,495.00 today.

1: Adjusted price after possible price splits or reverse-splits.

Nevro stock historical price chart

NVRO stock reached all-time highs on November 7th with a price of $108.20.

Nevro stock price target is $70.40

Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. You should not follow the analysts' NVRO stock price predictions in the hope that they will be met as they may be wrong and not met. We found 8 price predictions for NVRO stock posted in the last month:
NVRO stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-8-9Canaccord GenuityRaises Target$50.00$59.0018%
2019-8-9Bank of AmericaReiterates$70.00$74.005.7%
2019-8-9Bank of AmericaRaises Target$70.00$74.005.7%
2019-8-12JMP SecuritiesReiterates$70.00$90.0028.6%
2019-5-13Wells Fargo & CoReiterates$75.00$70.00-6.7%
2019-5-10Morgan StanleyLowers Target$70.00$64.00-8.6%
2019-3-20Canaccord GenuityReiterates$46.00$62.0034.8%
2019-3-20Bank of AmericaUpgrades$50.00$70.0040%
(in average)$62.60$70.4012.0%
The price target for Nevro stock is $70.40, moving in a range between $90.00 and $59.00. In average, analysts' outlook on NVRO price forecast is positive, improving the target by a 12.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

Nevro reported amazing results for 2018-Q4 on February. Nevro rocketed Earnings per Share (EPS) by 88.20%, beating experts estimates of $-0.17. Nevro posted $-0.32.
NVRO earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q1-n/a-0.5n/a
2017-Q2-n/a-0.4n/a
2017-Q32017-11-06-0.22-0.21n/a
2017-Q42018-02-22-0.14-0.15n/a
2018-Q12018-05-07-0.34-0.59n/a
2018-Q22018-08-02-0.3-0.35n/a
2018-Q32018-11-05-0.3-0.37n/a
2018-Q42019-02-21-0.17-0.32n/a
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a

Annual financial results

In 2018, Nevro annual sales rocketed an astounding 18.56% to $387.29 million USD from $326.67 marked in 2017. When comparing 2018 vs 2017, nonetheless, profit margin (that is, the net income divided by revenues) declined a -1.48% to -12.70%.

NVRO annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$24 M-$-26.17 M-111.4%-
2014$33 M38.61%$-30.68 M-94.2%17.23%
2015$70 M113.69%$-67.43 M-96.9%119.79%
2016$229 M228.28%$-31.78 M-13.9%-52.87%
2017$327 M42.96%$-36.66 M-11.2%15.36%
2018$387 M18.56%$-49.21 M-12.7%34.23%

Quarterly financial results

Nevro posted $107.94 M in revenues for 2018-Q4, a 12.88% up compared to previous quarter. Reported quarter earnings marked $-9.61 million with a profit margin of -8.90%. Profit margin appreciated a 2.88% compared to previous quarter when profit margin was -11.78%. When comparing revenues to same quarter last year, Nevro sales marked a superb growth and boosted a 10.19%.
NVRO quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q1$68 M-$-14.51 M-21.2%-
2017-Q2$78 M14.00%$-11.61 M-14.9%-19.99%
2017-Q3$82 M5.43%$-6.23 M-7.6%-46.34%
2017-Q4$98 M19.10%$-4.31 M-4.4%-30.80%
2018-Q1$88 M-10.54%$-17.71 M-20.2%310.88%
2018-Q2$96 M9.64%$-10.62 M-11.1%-40.04%
2018-Q3$96 M-0.47%$-11.27 M-11.8%6.07%
2018-Q4$108 M12.88%$-9.61 M-8.9%-14.72%

Nevro ownership

When you are planning to buy a company, it's always worth to have a look its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Nevro, 2.87% of all outstanding shares are owned by its staff.

Bearish positions for NVRO stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to Nevro:

NVROABMDISRGTMO
Market cap$3.3 B$10.1 B$65.8 B$123.0 B
Total shares31.0 M45.2 M115.6 M401.0 M
Float shares28.2 M41.8 M114.4 M400.0 M
  - Institutional holdings (%)111.9%89.8%89.1%90.7%
  - Insider holdings (%)2.9%4.1%1.0%0.2%
Shares in short selling0.0%0.0%0.0%0.0%

Nevro summary

Friday, November 15th, 2019
Open$105.14
Close$105.19
Day range$104.52 - $106.07
Previous close$104.98
Session gain0.20%
Average true range$4.29
50d mov avg$87.93
100d mov avg$79.62
200d mov avg$68.42
Daily patternlt01a
Weekly pattern lt06a

Nevro performance

Stocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. For Nevro, the benchmark is made against ABIOMED, Intuitive Surgical and Thermo Fisher Scientific.
Stock3m6m12m
NVRONevro30.25%69.03%160.69%
ABMDABIOMED15.66%-14.30%-30.19%
ISRGIntuitive Surgica...14.95%16.20%9.84%
TMOThermo Fisher Sci...11.18%17.38%27.62%

Nevro competitors

One check before investing in any stock is to review a list of its competitors, in this case for Nevro. We picked 3 companies as Nevro competitors as they are in the same industry or have similar market objectives.